{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:31:10Z","timestamp":1769275870903,"version":"3.49.0"},"reference-count":14,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,8,24]]},"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>A 35-year-old woman (gravida 1, para 0) underwent termination of pregnancy (ToP) at 12 weeks of gestation. One month after ToP, she experienced significant vaginal bleeding and the mass with blood flow was identified on imaging. The presence of a placental polyp with arteriovenous malformation (AVM) was suspected on transvaginal sonography and MRI. Since the bleeding had ceased when she visited our hospital, we decided to treat the placental polyp with AVM with gonadotropin-releasing hormone (GnRH) antagonist therapy instead of surgery. Two months after GnRH antagonist treatment, the mass and blood flow in the uterus disappeared. Menstruation resumed 1\u2009month after the completion of treatment. In our case, we were able to successfully treat placental polyps with AVM using GnRH antagonist therapy.<\/jats:p>","DOI":"10.1136\/bcr-2021-244664","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T22:50:14Z","timestamp":1631141414000},"page":"e244664","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Placental polyp with arteriovenous malformation treated with a gonadotoropin-releasing hormone antagonist"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8727-8958","authenticated-orcid":false,"given":"Mayuko","family":"Goda","sequence":"first","affiliation":[{"name":"Obstetrics and gynaecology, Seirei Hamamatsu Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Obstetrics and gynaecology, Seirei Hamamatsu Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Obstetrics and gynaecology, Seirei Hamamatsu Hospital, Hamamatsu, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"2025082709533405000_14.9.e244664.1","first-page":"538","article-title":"Differential diagnosis and management of placental polyp and uterine arteriovenous malformation: case reports and review of the literature","volume":"12","author":"Ishihara","year":"2016","journal-title":"Womens Health"},{"key":"2025082709533405000_14.9.e244664.2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-200301000-00016"},{"key":"2025082709533405000_14.9.e244664.3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jog.12139","article-title":"Acquired uterine arteriovenous malformation developing in retained products of conception: a diagnostic dilemma","volume":"40","author":"Goyal","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"2025082709533405000_14.9.e244664.4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jogc.2018.07.018","article-title":"Resolution of uterine arteriovenous malformation and maintenance of reproduction in 20 women treated with a GnRH agonist concomitantly with an aromatase inhibitor and tranexamic acid","volume":"41","author":"Vilos","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"2025082709533405000_14.9.e244664.5","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ajog.2011.01.070","article-title":"Modern management of hypervascular placental polypoid mass following spontaneous abortion: a case report and literature review","volume":"205","author":"Marques","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2025082709533405000_14.9.e244664.6","doi-asserted-by":"crossref","first-page":"731.e1","DOI":"10.1016\/j.ajog.2015.12.024","article-title":"Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity\/arteriovenous malformations","volume":"214","author":"Timor-Tritsch","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2025082709533405000_14.9.e244664.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00443-7"},{"key":"2025082709533405000_14.9.e244664.8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jmig.2014.04.015","article-title":"A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma","volume":"21","author":"Song","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"2025082709533405000_14.9.e244664.9","article-title":"Shortened cervix in the subsequent pregnancy after embolization for postpartum cervical hemorrhage","volume":"2014","author":"Kozinszky","year":"2014","journal-title":"Case Rep Obstet Gynecol"},{"key":"2025082709533405000_14.9.e244664.10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/ajo.12228","article-title":"Efficacy of transarterial embolisation in the management of post-partum haemorrhage and its impact on subsequent pregnancies","volume":"54","author":"Inoue","year":"2014","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025082709533405000_14.9.e244664.11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/AOG.0b013e3181f7381f","article-title":"Resolution of uterine arteriovenous malformation and successful pregnancy after treatment with a gonadotropin-releasing hormone agonist","volume":"117","author":"Nonaka","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2025082709533405000_14.9.e244664.12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AOG.0000000000003141","article-title":"Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Osuga","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2025082709533405000_14.9.e244664.13","doi-asserted-by":"publisher","DOI":"10.1007\/BF02213716"},{"key":"2025082709533405000_14.9.e244664.14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.tjog.2014.12.016","article-title":"Choosing the optimal therapeutic strategy for placental polyps using power Doppler color scoring: transarterial embolization followed by hysteroscopic resection or expectant management?","volume":"55","author":"Mori","year":"2016","journal-title":"Taiwan J Obstet Gynecol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-244664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:53:44Z","timestamp":1756313624000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-244664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":14,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,8]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/bcr-2021-244664"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-244664","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}